0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceutical Characterization Service Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-30P11501
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Characterization Service Market Research Report 2022
BUY CHAPTERS

Global Biopharmaceutical Characterization Service Market Research Report 2025

Code: QYRE-Auto-30P11501
Report
January 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical Characterization Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical Characterization Service Market

Biopharmaceutical Characterization Service Market

The global market for Biopharmaceutical Characterization Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biopharmaceutical characterization service refers to a range of analytical techniques and services used to assess the quality, safety, and efficacy of biopharmaceutical products. These services are typically offered by specialized contract research organizations (CROs) or analytical laboratories.
Biopharmaceutical characterization involves the detailed analysis of various attributes of a biopharmaceutical product, including its chemical composition, physical properties, stability, impurity profile, and biological activity. This characterization is crucial for ensuring the quality and consistency of biopharmaceutical products throughout their development, manufacturing, and regulatory approval processes.
Some common techniques used in biopharmaceutical characterization include:
1. Mass spectrometry: Used to identify and quantify the protein or peptide components of a biopharmaceutical product, as well as detect any modifications or impurities.
2. Chromatography: Various chromatographic techniques, such as high-performance liquid chromatography (HPLC) or size-exclusion chromatography (SEC), are used to separate and analyze the components of a biopharmaceutical product.
3. Spectroscopy: Techniques like nuclear magnetic resonance (NMR) spectroscopy or infrared (IR) spectroscopy are used to analyze the chemical structure and composition of biopharmaceuticals.
4. Bioassays: These are biological tests used to assess the biological activity and potency of a biopharmaceutical product. Examples include cell-based assays or enzyme activity assays.
5. Particle analysis: Techniques like dynamic light scattering (DLS) or microscopy are used to analyze the size, shape, and aggregation state of particles in biopharmaceutical formulations.
Biopharmaceutical characterization services are essential for ensuring the safety, efficacy, and regulatory compliance of biopharmaceutical products. They help pharmaceutical companies and researchers understand the critical quality attributes of their products, optimize their manufacturing processes, and meet regulatory requirements.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Characterization Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Characterization Service.
The Biopharmaceutical Characterization Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical Characterization Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Characterization Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biopharmaceutical Characterization Service Market Report

Report Metric Details
Report Name Biopharmaceutical Characterization Service Market
CAGR 5%
Segment by Type
Segment by Application
  • Enterprise
  • Research Institute
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SGS, Alfa Chemistry, Intertek, Eurofins Scientific, Solvias, Center for Biopharma Analysis, Bioneeds, Vproteomics, Cambrex, Merck, Drug Development Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biopharmaceutical Characterization Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical Characterization Service Market report?

Ans: The main players in the Biopharmaceutical Characterization Service Market are SGS, Alfa Chemistry, Intertek, Eurofins Scientific, Solvias, Center for Biopharma Analysis, Bioneeds, Vproteomics, Cambrex, Merck, Drug Development Solutions

What are the Application segmentation covered in the Biopharmaceutical Characterization Service Market report?

Ans: The Applications covered in the Biopharmaceutical Characterization Service Market report are Enterprise, Research Institute

What are the Type segmentation covered in the Biopharmaceutical Characterization Service Market report?

Ans: The Types covered in the Biopharmaceutical Characterization Service Market report are Protein Analysis, Peptide Analysis

Recommended Reports

Biopharma Testing Services

Analytical Testing & Characterization

Drug & Clinical Laboratory Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Characterization Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Protein Analysis
1.2.3 Peptide Analysis
1.3 Market by Application
1.3.1 Global Biopharmaceutical Characterization Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Characterization Service Market Perspective (2020-2031)
2.2 Global Biopharmaceutical Characterization Service Growth Trends by Region
2.2.1 Global Biopharmaceutical Characterization Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical Characterization Service Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical Characterization Service Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical Characterization Service Market Dynamics
2.3.1 Biopharmaceutical Characterization Service Industry Trends
2.3.2 Biopharmaceutical Characterization Service Market Drivers
2.3.3 Biopharmaceutical Characterization Service Market Challenges
2.3.4 Biopharmaceutical Characterization Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Characterization Service Players by Revenue
3.1.1 Global Top Biopharmaceutical Characterization Service Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical Characterization Service Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical Characterization Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical Characterization Service Revenue
3.4 Global Biopharmaceutical Characterization Service Market Concentration Ratio
3.4.1 Global Biopharmaceutical Characterization Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Characterization Service Revenue in 2024
3.5 Global Key Players of Biopharmaceutical Characterization Service Head office and Area Served
3.6 Global Key Players of Biopharmaceutical Characterization Service, Product and Application
3.7 Global Key Players of Biopharmaceutical Characterization Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Characterization Service Breakdown Data by Type
4.1 Global Biopharmaceutical Characterization Service Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical Characterization Service Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical Characterization Service Breakdown Data by Application
5.1 Global Biopharmaceutical Characterization Service Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical Characterization Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical Characterization Service Market Size (2020-2031)
6.2 North America Biopharmaceutical Characterization Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical Characterization Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Characterization Service Market Size (2020-2031)
7.2 Europe Biopharmaceutical Characterization Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical Characterization Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Characterization Service Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical Characterization Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical Characterization Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical Characterization Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Characterization Service Market Size (2020-2031)
9.2 Latin America Biopharmaceutical Characterization Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical Characterization Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Characterization Service Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical Characterization Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical Characterization Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SGS
11.1.1 SGS Company Details
11.1.2 SGS Business Overview
11.1.3 SGS Biopharmaceutical Characterization Service Introduction
11.1.4 SGS Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.1.5 SGS Recent Development
11.2 Alfa Chemistry
11.2.1 Alfa Chemistry Company Details
11.2.2 Alfa Chemistry Business Overview
11.2.3 Alfa Chemistry Biopharmaceutical Characterization Service Introduction
11.2.4 Alfa Chemistry Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.2.5 Alfa Chemistry Recent Development
11.3 Intertek
11.3.1 Intertek Company Details
11.3.2 Intertek Business Overview
11.3.3 Intertek Biopharmaceutical Characterization Service Introduction
11.3.4 Intertek Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.3.5 Intertek Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Biopharmaceutical Characterization Service Introduction
11.4.4 Eurofins Scientific Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 Solvias
11.5.1 Solvias Company Details
11.5.2 Solvias Business Overview
11.5.3 Solvias Biopharmaceutical Characterization Service Introduction
11.5.4 Solvias Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.5.5 Solvias Recent Development
11.6 Center for Biopharma Analysis
11.6.1 Center for Biopharma Analysis Company Details
11.6.2 Center for Biopharma Analysis Business Overview
11.6.3 Center for Biopharma Analysis Biopharmaceutical Characterization Service Introduction
11.6.4 Center for Biopharma Analysis Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.6.5 Center for Biopharma Analysis Recent Development
11.7 Bioneeds
11.7.1 Bioneeds Company Details
11.7.2 Bioneeds Business Overview
11.7.3 Bioneeds Biopharmaceutical Characterization Service Introduction
11.7.4 Bioneeds Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.7.5 Bioneeds Recent Development
11.8 Vproteomics
11.8.1 Vproteomics Company Details
11.8.2 Vproteomics Business Overview
11.8.3 Vproteomics Biopharmaceutical Characterization Service Introduction
11.8.4 Vproteomics Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.8.5 Vproteomics Recent Development
11.9 Cambrex
11.9.1 Cambrex Company Details
11.9.2 Cambrex Business Overview
11.9.3 Cambrex Biopharmaceutical Characterization Service Introduction
11.9.4 Cambrex Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.9.5 Cambrex Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical Characterization Service Introduction
11.10.4 Merck Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Drug Development Solutions
11.11.1 Drug Development Solutions Company Details
11.11.2 Drug Development Solutions Business Overview
11.11.3 Drug Development Solutions Biopharmaceutical Characterization Service Introduction
11.11.4 Drug Development Solutions Revenue in Biopharmaceutical Characterization Service Business (2020-2025)
11.11.5 Drug Development Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biopharmaceutical Characterization Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Protein Analysis
 Table 3. Key Players of Peptide Analysis
 Table 4. Global Biopharmaceutical Characterization Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Biopharmaceutical Characterization Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biopharmaceutical Characterization Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Biopharmaceutical Characterization Service Market Share by Region (2020-2025)
 Table 8. Global Biopharmaceutical Characterization Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Biopharmaceutical Characterization Service Market Share by Region (2026-2031)
 Table 10. Biopharmaceutical Characterization Service Market Trends
 Table 11. Biopharmaceutical Characterization Service Market Drivers
 Table 12. Biopharmaceutical Characterization Service Market Challenges
 Table 13. Biopharmaceutical Characterization Service Market Restraints
 Table 14. Global Biopharmaceutical Characterization Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Biopharmaceutical Characterization Service Market Share by Players (2020-2025)
 Table 16. Global Top Biopharmaceutical Characterization Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Characterization Service as of 2024)
 Table 17. Ranking of Global Top Biopharmaceutical Characterization Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Biopharmaceutical Characterization Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Biopharmaceutical Characterization Service, Headquarters and Area Served
 Table 20. Global Key Players of Biopharmaceutical Characterization Service, Product and Application
 Table 21. Global Key Players of Biopharmaceutical Characterization Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Biopharmaceutical Characterization Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Biopharmaceutical Characterization Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Biopharmaceutical Characterization Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Biopharmaceutical Characterization Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Biopharmaceutical Characterization Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Biopharmaceutical Characterization Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Biopharmaceutical Characterization Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Biopharmaceutical Characterization Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Biopharmaceutical Characterization Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Biopharmaceutical Characterization Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Biopharmaceutical Characterization Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Biopharmaceutical Characterization Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Biopharmaceutical Characterization Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Biopharmaceutical Characterization Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Biopharmaceutical Characterization Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Biopharmaceutical Characterization Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Biopharmaceutical Characterization Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biopharmaceutical Characterization Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Biopharmaceutical Characterization Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Biopharmaceutical Characterization Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Biopharmaceutical Characterization Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Biopharmaceutical Characterization Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Biopharmaceutical Characterization Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. SGS Company Details
 Table 47. SGS Business Overview
 Table 48. SGS Biopharmaceutical Characterization Service Product
 Table 49. SGS Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 50. SGS Recent Development
 Table 51. Alfa Chemistry Company Details
 Table 52. Alfa Chemistry Business Overview
 Table 53. Alfa Chemistry Biopharmaceutical Characterization Service Product
 Table 54. Alfa Chemistry Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 55. Alfa Chemistry Recent Development
 Table 56. Intertek Company Details
 Table 57. Intertek Business Overview
 Table 58. Intertek Biopharmaceutical Characterization Service Product
 Table 59. Intertek Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 60. Intertek Recent Development
 Table 61. Eurofins Scientific Company Details
 Table 62. Eurofins Scientific Business Overview
 Table 63. Eurofins Scientific Biopharmaceutical Characterization Service Product
 Table 64. Eurofins Scientific Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 65. Eurofins Scientific Recent Development
 Table 66. Solvias Company Details
 Table 67. Solvias Business Overview
 Table 68. Solvias Biopharmaceutical Characterization Service Product
 Table 69. Solvias Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 70. Solvias Recent Development
 Table 71. Center for Biopharma Analysis Company Details
 Table 72. Center for Biopharma Analysis Business Overview
 Table 73. Center for Biopharma Analysis Biopharmaceutical Characterization Service Product
 Table 74. Center for Biopharma Analysis Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 75. Center for Biopharma Analysis Recent Development
 Table 76. Bioneeds Company Details
 Table 77. Bioneeds Business Overview
 Table 78. Bioneeds Biopharmaceutical Characterization Service Product
 Table 79. Bioneeds Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 80. Bioneeds Recent Development
 Table 81. Vproteomics Company Details
 Table 82. Vproteomics Business Overview
 Table 83. Vproteomics Biopharmaceutical Characterization Service Product
 Table 84. Vproteomics Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 85. Vproteomics Recent Development
 Table 86. Cambrex Company Details
 Table 87. Cambrex Business Overview
 Table 88. Cambrex Biopharmaceutical Characterization Service Product
 Table 89. Cambrex Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 90. Cambrex Recent Development
 Table 91. Merck Company Details
 Table 92. Merck Business Overview
 Table 93. Merck Biopharmaceutical Characterization Service Product
 Table 94. Merck Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 95. Merck Recent Development
 Table 96. Drug Development Solutions Company Details
 Table 97. Drug Development Solutions Business Overview
 Table 98. Drug Development Solutions Biopharmaceutical Characterization Service Product
 Table 99. Drug Development Solutions Revenue in Biopharmaceutical Characterization Service Business (2020-2025) & (US$ Million)
 Table 100. Drug Development Solutions Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Biopharmaceutical Characterization Service Picture
 Figure 2. Global Biopharmaceutical Characterization Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biopharmaceutical Characterization Service Market Share by Type: 2024 VS 2031
 Figure 4. Protein Analysis Features
 Figure 5. Peptide Analysis Features
 Figure 6. Global Biopharmaceutical Characterization Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biopharmaceutical Characterization Service Market Share by Application: 2024 VS 2031
 Figure 8. Enterprise Case Studies
 Figure 9. Research Institute Case Studies
 Figure 10. Biopharmaceutical Characterization Service Report Years Considered
 Figure 11. Global Biopharmaceutical Characterization Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Biopharmaceutical Characterization Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Biopharmaceutical Characterization Service Market Share by Region: 2024 VS 2031
 Figure 14. Global Biopharmaceutical Characterization Service Market Share by Players in 2024
 Figure 15. Global Top Biopharmaceutical Characterization Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Characterization Service as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical Characterization Service Revenue in 2024
 Figure 17. North America Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Biopharmaceutical Characterization Service Market Share by Country (2020-2031)
 Figure 19. United States Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Biopharmaceutical Characterization Service Market Share by Country (2020-2031)
 Figure 23. Germany Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Biopharmaceutical Characterization Service Market Share by Region (2020-2031)
 Figure 31. China Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Biopharmaceutical Characterization Service Market Share by Country (2020-2031)
 Figure 39. Mexico Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Biopharmaceutical Characterization Service Market Share by Country (2020-2031)
 Figure 43. Turkey Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Biopharmaceutical Characterization Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. SGS Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 47. Alfa Chemistry Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 48. Intertek Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 49. Eurofins Scientific Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 50. Solvias Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 51. Center for Biopharma Analysis Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 52. Bioneeds Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 53. Vproteomics Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 54. Cambrex Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 56. Drug Development Solutions Revenue Growth Rate in Biopharmaceutical Characterization Service Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart